Emerging districts: The evolution of Life Sciences real estate

Life sciences in the UK is heavily concentrated in three places: Cambridge, Oxford and London.

Between 2021 and 2023, £5.8 billion was invested in real estate for this sector – and £4.5 billion was in this “Golden Triangle”.

These already thriving markets are set to benefit from continuing investment, as the current government has set a target for the UK to become a “global science superpower”, while the opposition has also made life sciences a key priority, pledging to increase R&D by £10 billion a year.

But will the Golden Triangle retain its unassailable dominance as the sector expands, or will new hotspots emerge to challenge it?

Linesight convened an expert panel to discuss what makes a successful life sciences destination, the role of clusters in meeting the UK’s ambitions, and what tomorrow’s life sciences landscape might look like. 

You can read our takeaways from this rcoundable discussion by clicking download. 

• Giles Heather, Director – UK & Europe, Linesight
• Richard Papworth, Director, HDR
• John Hunt, Senior Adviser & Global Lead – Construction & Technology, Enterprise Ireland
• Tim Fry, Business Leader, Science UKIMEA, Arup
• Peter Gavican, Chief Operating Officer, Eagle Street
• Gareth Roberts, Head of Development – Innovation & Life Science, British Land
• Fatos Peja, Design Principal, HDR
• Liz Hasmon, Editor-in-chief, BE News (CHAIR)
• Balwinder Brar, Senior Technical Services Manager, Overbury
• Priya Shah, Associate Director – Life Sciences, Linesight
• Edmund Vaughan, Operations Director (Design), chapmanbdsp
• Nick Pell, Director, T-A Labs

You can read our takeaways from this roundtable discussion by clicking on 'download report'.